FDA grants Fast Track designation for Keryx Biopharmaceuticals' KRX-0401
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentiall...
News-Medical-Net,
Wed Dec 02 21:45:04 PST 2009
• Found on Yahoo! News
Anti-cancer antibodies provide hope
NILAI: Two anti-cancer antibodies which may provide hope for patients suffering from colorectal cancer are scheduled for human clinical trials by 2011. The humanised antibodies testing will...
MalaysiaNews.net,
Sun Dec 06 17:19:32 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Anti-cancer antibodies provide hope
NILAI: Two anti-cancer antibodies which may provide hope for patients suffering from colorectal cancer are scheduled for human clinical trials by 2011.
The New Straits Times,
Sun Dec 06 16:09:37 PST 2009
• Found on Yahoo! News
Skymark Research Initiates Independent Research Coverage on Keryx Biopharmaceutica...
CALGARY, Alberta -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Keryx Biopharmaceuticals, Inc. . Skymark Resear...
GlobeNewswire via Yahoo! Finance,
Wed Dec 02 06:55:17 PST 2009
• Found on Yahoo! News
Keryx treatment gets faster FDA review
Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
AP via Yahoo! News,
Wed Dec 02 12:42:04 PST 2009
• Found on Yahoo! News
A huge investment
Your Nov. 29 front-page article on biologic drugs highlighted the importance of these products and their contributions to human health.
The News & Observer,
Fri Dec 04 16:31:19 PST 2009
• Found on Yahoo! News
INNO BIOLOGICS AND CIM SUCCESSFULLY HUMANISED - TWO ANTI CANCER ANTIBODIES
ATTENTION EDITOR BUSINESS DESK Putra Nilai, 3 December 2009 â Inno Biologics Sdn Bhd., the first contract manufacturing organisation (CMO) for biopharmaceuticals production in Malaysia, and...
Bernama via Yahoo! Malaysia News,
Wed Dec 02 20:16:54 PST 2009
• Found on Yahoo! News
Keryx treatment gets faster FDA review
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
Newsday,
Wed Dec 02 14:56:55 PST 2009
• Found on Yahoo! News
Stock Watch: InvestorSoup.com Issues Market Alert for Keryx Pharmaceuticals Inc.
DALLAS -- InvestorSoup.com announces an investment report featuring Keryx Biopharmaceuticals Inc. . The report includes financial, comparative and investment analyses, and pertinent industr...
GlobeNewswire via Yahoo! Finance,
Thu Dec 03 04:30:00 PST 2009
• Found on Yahoo! News
People In The News
NEW YORK (GenomeWeb News)
GenomeWeb News,
Fri Dec 04 12:30:53 PST 2009
• Found on Yahoo! News
V+ Invests in AmVac AG
The Swiss biopharmaceuticals company AmVac AG in Zug has joined forces with the long-term strategic investor V+ GmbH & Co Fonds 2 KG. The private equity company based in Dresden has investe...
PR Newswire via Yahoo! Finance,
Thu Dec 03 01:50:00 PST 2009
• Found on Yahoo! News
Markets in Brief
Teva Pharmaceutical Industries and specialty biopharmaceuticals company Shire have settled their dispute over supplies, with no money changing hands.
Haaretz Daily,
Wed Dec 02 16:12:20 PST 2009
• Found on Yahoo! News
Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatm...
NEW YORK, Dec. 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the U.S.
redOrbit,
Wed Dec 02 08:07:50 PST 2009
• Found on Yahoo! News
Keryx treatment gets faster FDA review
Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potentialcancer treatment Perifosine a fast-track review process.
FOX 12 Idaho,
Wed Dec 02 13:19:57 PST 2009
• Found on Yahoo! News
FDA Fast Tracks Keryx Immune-System Cancer Drug; Shares Rise
Keryx Biopharmaceuticals Inc.'s (KERX) experimental drug to treat a kind of cancer in white blood cells received fast-track status from the Food and Drug Administration.
Nasdaq,
Wed Dec 02 06:47:23 PST 2009
• Found on Yahoo! News
Keryx treatment gets faster FDA review
NEW YORK
Rocky Mount Telegram,
Wed Dec 02 12:57:27 PST 2009
• Found on Yahoo! News
Keryx treatment gets faster FDA review
(AP:NEW YORK) Keryx Biopharmaceuticals Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
INO News,
Wed Dec 02 06:56:34 PST 2009
• Found on Yahoo! News
Dyax gets US FDA nod for ecallantide to treat hereditary angioedema
Dyax Corp announced that the US Food and Drug Administration (FDA) has granted approval for Kalbitor (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patie...
PharmaBiz,
Fri Dec 04 00:51:25 PST 2009
• Found on Yahoo! News
GIND scientists identify drug treatments that can normalize neuron development in ...
Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that two main causes of AD amyloid-beta (A
News-Medical-Net,
Fri Dec 04 00:16:04 PST 2009
• Found on Yahoo! News